Skip to main content
Log in

Optimum treatment of intracellular infections is based on clinical data

  • New Drugs and Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Moulder JW. Comparative biology of intracellular parasitism. Microbiol Rev 1985; 49: 239–337

    Google Scholar 

  2. Maurin M, Raoult D. Optimum treatment of intracellular infections. Drugs 1996 Jul; 52(1): 45–59

    Article  PubMed  CAS  Google Scholar 

  3. Hope and Longmore. Oxford handbook of clinical medicine. Oxford University Press, 1985

  4. Martindale. The Extra Pharmacopoeia, 31st ed. London: Pharmaceutical Press, 1996

  5. Drancourt M, Raoult D. Antimicrobial therapy of rickettsial spotted fever. In Raoult D, editor. Antimicrobial agents and intracellular pathogens. Boca Raton: CRC Press, 1993

    Google Scholar 

  6. Magat AH, Alger LS, Nagey DA, et al. Double-blind randomized study comparing amoxicillin and erythromycin for the treatment of Chlamydia trachomatis in pregnancy. Obstet Gynecol 1993; 81: 745–9

    PubMed  CAS  Google Scholar 

  7. Antibiotic Guidelines 1994/1995. 8th ed. North Melbourne (VIC): Victorian Medical Postgraduate Foundation, Therapeutics Committee

  8. Rowe B, Ward LR, Threlfall EJ. Ciprofloxacin-resistant Salmonella typhi in the UK. Lancet 1995; 346: 1302

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Optimum treatment of intracellular infections is based on clinical data. Drugs Ther. Perspect 10, 8–11 (1997). https://doi.org/10.2165/00042310-199710110-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199710110-00003

Keywords

Navigation